• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Halozyme Therapeutics Inc

+ Add to Watchlist

HALO:US

8.5200 USD 0.1000 1.19%

As of 20:10:00 ET on 11/21/2014.

Company Profile for Halozyme Therapeutics Inc (HALO)

Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.

Contact Information

Halozyme Therapeutics Inc

11388 Sorrento Valley Road
San Diego, CA 92121
United States
Phone: 1-858-794-8889
Fax: 1-858-259-2539

Key Executives for Halozyme Therapeutics Inc (HALO)

Helen TorleyPresident/CEODavid A RamsayChief Financial Officer
H Michael Shepard "Mike"VP/Chief Scientific Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil